Black Rock Inc. Cardiol Therapeutics Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Shares
2 transactions
Others Institutions Holding CRDL
# of Institutions
43Shares Held
6.7MCall Options Held
37.6KPut Options Held
0-
Tejara Capital LTD London, X03.27MShares$3.33 Million2.06% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD857KShares$874,5350.22% of portfolio
-
Lion Street Advisors, LLC340KShares$346,8250.15% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9293KShares$298,9170.15% of portfolio
-
Pvg Asset Management Corp Golden, CO283KShares$289,1411.46% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $63.2M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...